Sally Glaser

Administrative Appointments

• Chief Executive Officer, Cancer Prevention Institute of California (formerly Northern California Cancer Center) (2009 - present)
• Interim Executive Director, Nothern California Cancer Center (2008 - 2009)
• Director, Greater Bay Area Cancer Registry, Cancer Prevention Institute of California (Northern California Cancer Center) (2005 - present)
• Director, Surveillance Research, Northern California Cancer Center (2000 - 2006)

Professional Education

Internet Links

• www.cpic.org

Current Research Interests

Research

Hodgkin lymphoma: Dr. Glaser has conducted numerous descriptive studies in the epidemiology of Hodgkin lymphoma. Her analytic work includes population-based studies of Hodgkin lymphoma in women and research to characterize the epidemiologic features of Epstein-Barr virus (EBV)-associated Hodgkin lymphoma, including in a large population-based California case series (n>1,000). With colleagues Dr. Richard Ambinder and Dr. Margaret Gulley, Dr. Glaser evaluated the reliability of EBV detection assays, generating interpretation guidelines to minimize this variation. Dr. Glaser’s current research interests in Hodgkin lymphoma involve genetic determinants of risk and their interaction with environmental factors.

Breast cancer: Dr. Glaser has been involved in Surveillance Research studies of incidence and survival patterns of breast cancer. Her analytic studies have focused on immune function modulators. These include a population-based study of EBV and risk of breast cancer and subsequent work with Dr. Gulley to develop a comprehensive panel of novel EBV assays and apply them to a representative group of breast tumors. Dr. Glaser also conducted research to test the hypothesis that racial/ethnic variation in human leukocyte antigen genotypes explains some portion of racial/ethnic variation in breast cancer incidence.

Surveillance Research: Within the Greater Bay Area Cancer Registry, part of the NCI's SEER program, Dr. Glaser built a research program dedicated to the insightful use of population-based cancer registry data to inform understanding of site-specific cancer incidence and survival patterns in various population subgroups, particularly those defined by race/ethnicity and socioeconomic status. The Surveillance Research group has had particular interest in breast, colon and prostate cancers, and in lymphomas. Substantial effort has gone to understanding and improving the quality and completeness of cancer registry variables central to ongoing research interests. New interests include examining disparities in cancer incidence and survival, and the influence of the built and social environment on cancer incidence and outcomes.

Administration

Registry leadership: Dr. Glaser joined the Greater Bay Area Cancer Registry in 1993 to oversee scientific uses of registry data and, in 2005, undertook leadership of the Registry. She and her registry team are committed to excellence in registry function and to preparing for changes facing cancer registration, including increasing electronic data transmission and expanding data content to include more information on biomarkers, comorbidities and intermediate endpoints such as recurrence.

Dr. Glaser assumed leadership of the Northern California Cancer Center in 2009. The organization was renamed the Cancer Prevention Institute of California in 2010.

Publications

• Increasing mastectomy rates for early-stage breast cancer? Population-based trends from California. Gomez SL, Lichtensztajn D, Kurian AW, Telli ML, Chang ET, Keegan TH, Glaser SL, Clarke CA. J Clin Oncol. 2010; 28 (10): e155-7; author reply e158
• Disparities in survival after Hodgkin lymphoma: a population-based study. Keegan TH, Clarke CA, Chang ET, Shema SJ, Glaser SL. Cancer Causes Control. 2009; 20 (10): 1881-92
• Recent trends in breast cancer incidence in US white women by county-level urban/rural and poverty status. Hausauer AK, Keegan TH, Chang ET, Glaser SL, Howe H, Clarke CA. BMC Med. 2009: 7 31
• Availability and utility of body mass index for population-based cancer surveillance. Keegan TH, Le GM, McClure LA, Glaser SL. Cancer Causes Control. 2008; 19 (1): 51-7
• Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996-2004. Carreon JD, Morton LM, Devesa SS, Clarke CA, Gomez SL, Glaser SL, Sakoda LC, Linet MS, Wang SS. Cancer Causes Control. 2008; 19 (10): 1171-81